Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three months ended March 31, 2023, and provided an operating forecast and business updates. Ligand management...
Novartis: Q1 Earnings Snapshot
Novartis: Q4 Earnings Snapshot
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that its partner Novan, Inc. (Nasdaq: NOVN) has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking...
Stocks that traded heavily or had substantial price changes Thursday: ViaSat, Nvidia rise; Cal-Maine Foods falls
Novartis: Q3 Earnings Snapshot
- Resulting entity to have broad portfolio of commercial product in dermatology and established pipeline of early and late-stage product candidates in development across multiple indications - Company...